TEG-based transfusion protocol is associated with decreased blood product use without increased risk of hemoperitoneum.

Brittany BromfieldRoberto TellezDempsey L HughesRebecca BrownMargaret AndrzejewskiAditi BawaFei-Pi LinMitchell TublinDarrell TriulziArmando GanozaAndrés Duarte-Rojo

Published in: Hepatology communications (2023)

Implementation of a pre-paracentesis TEG-based transfusion protocol for patients with cirrhosis successfully resulted in decreased blood product use with no associated increase in incidence of PPH.

Keyphrases

cardiac surgery
randomized controlled trial
primary care
sickle cell disease
healthcare
risk factors
quality improvement